Navigation Links
VIVUS to Present at Two Upcoming Investor Conferences
Date:3/3/2010

MOUNTAIN VIEW, Calif., March 3 /PRNewswire-FirstCall/ -- VIVUS, Inc. (Nasdaq: VVUS) today announced that Timothy Morris, Chief Financial Officer, will present an overview of the company at two investment conferences during the month of March.

    The conference presentation schedule is as follows:

     Cowen and Company 30th Annual Health Care Conference
     March 10, 2010 at 9:30 a.m. ET
     The Boston Marriott Copley Place, Boston, MA

     Roth Capital Partners 22nd Annual OC Growth Stock
      Conference
     March 16, 2010 at 12:00 p.m. PT
     The Ritz Carlton, Dana Point, CA

A live audio webcast and 30-day archive of the presentations will be available on VIVUS' website at http://www.vivus.com.

About VIVUS

VIVUS is a biopharmaceutical company developing innovative, next- generation therapies to address unmet needs in obesity, sleep apnea, diabetes and sexual health. The company's lead product in clinical development, Qnexa(R), has completed phase 3 clinical trials for the treatment of obesity and an NDA has been filed and accepted by the FDA, with an action date of October 28, 2010. Qnexa is also in phase 2 clinical development for the treatment of type 2 diabetes and obstructive sleep apnea. In the area of sexual health, VIVUS is in phase 3 development with avanafil, a potentially best-in-class PDE5 inhibitor for the treatment of erectile dysfunction, and in phase 2 development of Luramist(TM) for the treatment of hypoactive sexual desire disorder (HSDD) in women. MUSE(R) (alprostadil), a first generation therapy for the treatment of ED, is already on the market and generating revenue for VIVUS. For more information about the company, please visit www.vivus.com.

    CONTACT:

    VIVUS, Inc.
    Timothy E. Morris
    Chief Financial Officer
    650-934-5200

    Investor Relations:
    The Trout Group
    Brian Korb
    646-378-2923

    Media Relations:
    Pure Communications, Inc.
    Dan Budwick
    973-271-6085

SOURCE VIVUS, Inc.

Back to top

RELATED LINKS
http://www.vivus.com

'/>"/>

SOURCE VIVUS, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. VIVUS Reports Third Quarter 2009 Highlights and Financial Results
2. VIVUS Announces Positive Results From Two Phase 3 Studies; Obese Patients on Qnexa Achieve Average Weight Loss up to 14.7% and Significant Improvements in Co-Morbidities
3. VIVUS to Present at Four Upcoming Healthcare Conferences
4. VIVUS to Present at the Canaccord Adams 29th Annual Global Growth Conference
5. VIVUS to Present at the Needham and Company Life Sciences Conference
6. Data on VIVUS Qnexa To Be Presented During Two Podium Presentations at ADA Annual Meeting
7. VIVUS Reports First Quarter 2009 Financial Results and Highlights
8. PDI to Present at the ROTH Capital Partners 22nd Annual OC Growth Stock Conference
9. Nutrastar International, Inc. to Present at the 2010 Rodman & Renshaw Annual China Investment Conference in Beijing
10. OncoGenex Pharmaceuticals to Present at RBC Capital Markets Healthcare Conference
11. Creating a Better Health Ecosystem Focus of Presentation by Aleres Dr. Gordon Norman at Population Health & Disease Management Colloquium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2017)... ... June 26, 2017 , ... Two new members were elected to the University ... 2017: Jeremy Nowak, President, J Nowak Strategy and Michele Masucci, Ph.D., Vice President for ... Glen N. Gaulton and Kenneth L. Kring, and re-election of David P. Holveck and ...
(Date:6/23/2017)... BELLINGHAM, Washington, USA, and CARDIFF, UK (PRWEB) , ... June 23, ... ... National Lab (LANL), and Brian Lula, president of Physik Instrumente USA, have been selected ... for optics and photonics . , The two have been invited along with other ...
(Date:6/22/2017)... (PRWEB) , ... June 21, 2017 , ... ... attracting and hiring top executive talent in the life sciences industry, today announces ... Manufacturing company. The partnership takes full advantage of Beaker’s expertise in executive ...
(Date:6/22/2017)... ... June 22, 2017 , ... AESKU.GROUP, an innovation leader ... & Technologien GmbH, thereby expanding its product portfolio to include allergy and food ... asthma, atopic eczema or a food allergy. Allergies are escalating to epidemic proportions ...
Breaking Biology Technology:
(Date:5/16/2017)... , May 16, 2017   Bridge Patient ... organizations, and MD EMR Systems , an ... partner for GE, have established a partnership to ... product and the GE Centricity™ products, including Centricity ... These new integrations will allow ...
(Date:4/24/2017)... Janice Kephart , former 9/11 ... Partners, LLP (IdSP) , today issues the following ... March 6, 2017 Executive Order: Protecting the ... be instilled with greater confidence, enabling the reactivation ... applications are suspended by until at least July ...
(Date:4/18/2017)...  Socionext Inc., a global expert in SoC-based imaging and computing ... M820, which features the company,s hybrid codec technology. A demonstration utilizing ... Inc., will be showcased during the upcoming Medtec Japan at Tokyo ... Las Vegas Convention Center April 24-27. ... Click here for an image ...
Breaking Biology News(10 mins):